Overview

A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects

Status:
RECRUITING

Trial end date:
2026-12-01

Target enrollment:

Participant gender:

Summary

Healthy adult subjects were selected to use TQC3302 inhalation spray to evaluate the safety, tolerability, and pharmacokinetic characteristics of single and multiple inhalations of TQC3302 inhalation spray in healthy participants.

Phase:

PHASE1

Details

Lead Sponsor:

Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.

Treatments:

Inhalation
Tiotropium Bromide